{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:02:28Z","timestamp":1790884948528,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.vaccine.2007.09.027","type":"journal-article","created":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T18:00:10Z","timestamp":1191261610000},"page":"8352-8358","source":"Crossref","is-referenced-by-count":54,"title":["HPV vaccine efficacy in preventing persistent cervical HPV infection: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"25","author":[{"given":"G.","family":"La Torre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"de Waure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Chiaradia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mannocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.09.027_bib1","unstructured":"World Health Organization. Viral cancer. Human papillomavirus. Available from http:\/\/www.who.int\/vaccine_research\/diseases\/viral_cancers\/en\/index3.html [accessed on February 9, 2007]."},{"issue":"5","key":"10.1016\/j.vaccine.2007.09.027_bib2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1086\/505982","article-title":"Genital human papillomavirus infection","volume":"43","author":"Dunne","year":"2006","journal-title":"Clin Inf Dis"},{"issue":"9490","key":"10.1016\/j.vaccine.2007.09.027_bib3","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(05)67069-9","article-title":"Worldwide distribution of human papillomavirus types in citologically normal women in the international agency for research on cancer HPV prevalence surveys: a pooled analysis","volume":"366","author":"Clifford","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2007.09.027_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejca.2004.07.005","article-title":"Prevalence of human papillomavirus infection in women in Turin, Italy","volume":"41","author":"Ronco","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.vaccine.2007.09.027_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2334-5-77","article-title":"Prevalence of human papillomavirus cervical infection in an Italian asymptomatic population","volume":"5","author":"Centurioni","year":"2005","journal-title":"BMC Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2007.09.027_bib6","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/jama.259.8.1199","article-title":"Papillomavirus in the vapor of carbon dioxide laser-treated verrucae","volume":"259","author":"Garden","year":"1988","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.vaccine.2007.09.027_bib7","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1001\/jama.261.18.2669","article-title":"Human papillomavirus type 16 DNA in periungual squamous cell carcinomas","volume":"261","author":"Moy","year":"1989","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2007.09.027_bib8","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jcv.2004.12.008","article-title":"The epidemiology of human papillomavirus infections","volume":"32","author":"Baseman","year":"2005","journal-title":"J Clin Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.09.027_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1288\/00005537-199201000-00002","article-title":"A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis","volume":"102","author":"Kashima","year":"1992","journal-title":"Laryngoscope"},{"key":"10.1016\/j.vaccine.2007.09.027_bib10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/oxfordjournals.epirev.a036020","article-title":"Epidemiology of genital human papillomavirus infection","volume":"10","author":"Koutsky","year":"1988","journal-title":"Epidemiol Rev"},{"issue":"9","key":"10.1016\/j.vaccine.2007.09.027_bib11","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1128\/JCM.31.9.2547-2549.1993","article-title":"Human papillomavirus and cutaneous warts in meat handlers","volume":"31","author":"Melchers","year":"1993","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2007.09.027_bib12","doi-asserted-by":"crossref","first-page":"930","DOI":"10.5858\/2003-127-930-HPEAPH","article-title":"Human papillomavirus: epidemiology and public health","volume":"127","author":"Schiffman","year":"2003","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.vaccine.2007.09.027_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.vaccine.2007.09.027_bib14","unstructured":"IARC. Human papillomaviruses. In: IARC monographs on the evaluation of carcinogenic risks to humans. 64th ed. Lyon: IARC Press; 1995."},{"issue":"5","key":"10.1016\/j.vaccine.2007.09.027_bib15","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2007.09.027_bib16","volume":"vol. 10","author":"International Agency for Research on Cancer (IARC)","year":"2005"},{"issue":"8","key":"10.1016\/j.vaccine.2007.09.027_bib17","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1128\/JCM.33.8.2058-2063.1995","article-title":"Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts","volume":"33","author":"Greer","year":"1995","journal-title":"J Clin Microbiol"},{"issue":"6 Suppl 1","key":"10.1016\/j.vaccine.2007.09.027_bib18","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/01.ogx.0000221187.63574.5c","article-title":"Vaccines for the prevention of human papillomavirus and associated gynecologic diseases: a review","volume":"61","author":"Ault","year":"2006","journal-title":"Obstet Gynecol Surv"},{"issue":"1","key":"10.1016\/j.vaccine.2007.09.027_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"issue":"5","key":"10.1016\/j.vaccine.2007.09.027_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2007.09.027_bib21","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1016\/j.vaccine.2006.04.068","article-title":"Immunologic responses following administration of a vaccine targeting human papillomavirus types 6, 11, 16, and 18","volume":"24","author":"Villa","year":"2006","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2007.09.027_bib22","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.bjc.6603469","article-title":"High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6\/11\/16\/18 L1 virus-like particle vaccine through 5 years of follow-up","volume":"95","author":"Villa","year":"2006","journal-title":"Br J Cancer"},{"issue":"9447","key":"10.1016\/j.vaccine.2007.09.027_bib23","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"issue":"9518","key":"10.1016\/j.vaccine.2007.09.027_bib24","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.vaccine.2007.09.027_bib25","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","article-title":"A controlled trial of a human papillomavirus type 16 vaccine","volume":"347","author":"Koutsky","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2007.09.027_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.AOG.0000192397.41191.fb","article-title":"Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial","volume":"107","author":"Mao","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"21\u201322","key":"10.1016\/j.vaccine.2007.09.027_bib27","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1016\/j.vaccine.2003.11.059","article-title":"Early assessment of the efficacy of a human papillomavirus type 16 L1 virus-like particle vaccine","volume":"22","author":"Brown","year":"2004","journal-title":"Vaccine"},{"issue":"9580","key":"10.1016\/j.vaccine.2007.09.027_bib28","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2007.09.027_bib29","unstructured":"Centers for Disease Control and Prevention. ACIP provisional recommendations for the use of quadrivalent HPV vaccine; 2006. Available from http:\/\/www.cdc.gov\/nip\/recs\/provisional_recs\/hpv.pdf [accessed on February 14, 2007]."},{"key":"10.1016\/j.vaccine.2007.09.027_bib30","unstructured":"EMEA. Relazione di valutazione pubblica europea (EPAR). Gardasil. EMEA\/H\/C\/703. [European public evaluation report. Gardasil. EMEA\/H\/C\/703]. Available from http:\/\/www.emea.europa.eu\/humandocs\/PDFs\/EPAR\/gardasil\/070306it1.pdf [accessed on March 05, 2007]."},{"key":"10.1016\/j.vaccine.2007.09.027_bib31","unstructured":"Ministero della Salute. Consiglio superiore di sanit\u00e0. Sessione XLVI. Sezioni congiunte II e III. Seduta dell\u201911 gennaio 2007 [Ministry of Health. Higher Health Council. XLVI Session. I and II joined Sections. January 11, 2007 session]."},{"issue":"3","key":"10.1016\/j.vaccine.2007.09.027_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/01.inf.0000253970.29190.5a","article-title":"Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial","volume":"26","author":"Reisinger","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2007.09.027_bib33","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jadohealth.2007.02.015","article-title":"Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant","volume":"40","author":"Pedersen","year":"2007","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.vaccine.2007.09.027_bib34","unstructured":"American Cancer Society News Center. ACS Recommends HPV Vaccine But Cervical Cancer Screening Still Necessary. Available from: http:\/\/www.cancer.org\/docroot\/NWS\/content\/NWS_1_1x_ACS_Recommends_HPV_Vaccine.asp [accessed on 05-03-2007]."},{"issue":"1","key":"10.1016\/j.vaccine.2007.09.027_bib35","first-page":"81","article-title":"Health technology assessment and vaccine: new needs and opportunities?","volume":"4","author":"La Torre","year":"2007","journal-title":"Ital J Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07010328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07010328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T23:24:12Z","timestamp":1629847452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07010328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":35,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0264410X07010328"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.09.027","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}